United States · 
Who invested in Aardvark Therapeutics?
Aardvark Therapeutics's investors include Cormorant Asset Management and Premier Partners.
United States · Series C startup
Who invested in Aardvark Therapeutics
Funding summaryUpdated 26 Oct 2026
$85Mraised across 1 round since 2024, from 1 source
- Latest round
- Series C, $85MMay 2024
- Investors
- 2
The rounds
- May 2024Series C$85M
Source recordedSEC filing: $85M sold, first sale May 2024
Founders and team
From Aardvark Therapeutics's own website and the SEC filings it signed: 3 on the team.
- Derrick LiChief Business Officer
- Nelson SunChief Operating Officer & Chief Financial Officer
- Tien-Li LeeExecutive Officer, Directori
On the board, as filediJeffrey ChiVictor Tong
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Aardvark Therapeutics
How much has Aardvark Therapeutics raised?
Aardvark Therapeutics has raised $85M across 1 round since 2024.
When did Aardvark Therapeutics last raise?
Aardvark Therapeutics's most recent round was a Series C of $85M in May 2024.
What was Aardvark Therapeutics's biggest round?
Its most recent round, $85M in May 2024, is also its largest on record.
Who backed Aardvark Therapeutics first?
Aardvark Therapeutics's first round on record, in May 2024, was backed by Cormorant Asset Management and Premier Partners.
What stage is Aardvark Therapeutics at?
Aardvark Therapeutics's latest named round is a Series C, in May 2024.
Where is Aardvark Therapeutics based?
Aardvark Therapeutics is based in the United States.
Companies like Aardvark Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.